<DOC>
	<DOCNO>NCT02308241</DOCNO>
	<brief_summary>The purpose study find effect , good bad , drug call ribavirin patient cancer . Ribavirin also study clinical trial patient various type cancer . These study demonstrate ribavirin safely give high dos dose used part treatment hepatitis C. Ribavirin know target protein call `` 4E '' turn central part cause cell grow , call ribosome . HPV-related cancer often abnormally high level 4E . The purpose study evaluate ribavirin may useful treatment patient advance cancer related HPV blocking activity 4E .</brief_summary>
	<brief_title>Ribavirin Patients With Recurrent/Metastatic ( R/M ) Human Papillomavirus ( HPV ) -Related Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<criteria>Recurrent and/or metastatic HPVrelated carcinoma cervix , anus , vagina , vulva , penis , oropharynx . The cancer diagnosis must confirm slide review MSKCC Department Pathology . HPV positive status must demonstrate HPV situhybridization ( ISH ) and/or p16 immunohistochemistry ( IHC ) . Note : For cervix squamous cancer , HPV ISH test p16 IHC test require , cervix squamous cancer presume HPVassociated . Adults ( ≥ 18 year age ) ECOG performance status 1 well Measurable disease accord RECIST 1.1 criterion Availability archive tumor tissue correlative study ( 5 unstained slide ) Adequate organ function , follow : Adequate bone marrow reserve : absolute neutrophil count ( ANC ) ≥ 1.5 X 109/L , platelet ≥ 160 X 109/L , hemoglobin ≥ 10 g/dL Hepatic : total bilirubin within ULN ( upper limit normal ) ; alkaline phosphatase ( AP ) , aspartate transaminase ( AST ) alanine transaminase ( ALT ) ≤ 2.0 X ULN Renal : Serum creatinine ≤ 1.3 mg/dL . Patients serum creatinine &gt; 1.3 mg/dL may eligible creatinine clearance ( CrCl ) ≥ 55 mL/min base standard Cockroft Gault formula . Ability swallow oral medication . Patients childbearing potential must negative serum pregnancy test within 14 day treatment . Patients must agree use reliable method birth control 6 month follow last dose study drug . At least one prior systemic therapy regimen R/M HPVrelated carcinoma History hemolytic anemia thalassemia Current treatment know prior treatment ribavirin Active infection serious underlie medical condition would impair patient 's ability receive protocol treatment . Current therapeutic anticoagulation Coumadin ( warfarin ) Known brain metastasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Ribavirin</keyword>
	<keyword>Human Papillomavirus ( HPV )</keyword>
	<keyword>Recurrent/Metastatic ( R/M )</keyword>
	<keyword>14-211</keyword>
</DOC>